Bayer HealthCare Pharmaceuticals Company Description
Take a pinch of Bayer, add a dash of Schering, put it in the oven of the US pharmaceuticals market, and you've got the recipe for Bayer HealthCare Pharmaceuticals. The US-based pharmaceuticals unit of Bayer Healthcare, the company was formed by combining the former Schering AG's Berlex subsidiary with the US prescription drug operations of Bayer. (Schering AG is now Bayer Schering Pharma.) The company is focused on specialty therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health, and several other serious chronic diseases such as multiple sclerosis and Parkinson's disease.
View the Comprehensive Company Description for Bayer HealthCare Pharmaceuticals
The Company Description provides a historical perspective of Bayer HealthCare Pharmaceuticals's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Bayer HealthCare Pharmaceuticals's evolution in the marketplace.
